This is (supposed to be) a reflective diary by a (not very) anonymous biomedical scientist who works somewhere in the south of England. One day this diary may well be submitted to the Health and Care Professions Council as evidence of ongoing continual professional development....
The HCPC sent their newsletter today. You can read it by clicking here. Some of the stuff in it was interesting, some dull. I found myself being rather thoughtful about the requests for opinions on the future direction of the HCPC. Back in the day this would have been something which I would have been only too keen to get involved. I had a look at the information and tried to enthuse myself, but that person who would have got involved isn’t me any more.
A shame?
Perhaps.
There’s been quite a lot of information circulating about the effects of COVID-19 on haemostasis. Here’s a rather good summary.
I can’t take credit for finding this myself. I shamelessly blagged this from a fellow blogger. I’m hoping that when Clare Does Science she will also be providing a resource for me as well… I’m cheeky like that.
One of the ways I do CPD is by signing up to every mailing list known to science in the desperate hope that I will get sent something worthy of note.
Some of the mailing lists are invaluable. Some not so. This morning I unsubscribed from LabTAG blog, The Scientist, Bioanalysis Zone, and Laboratory News. Whilst they are quite respectable publications, they aren’t for me.
CPD isn’t always productive…
The nice people at the BBTS emailed me
this morning.
“Accredited by the world-renowned
University of Manchester, the BBTS Specialist Certificate in Transfusion
Science Practice education course will provide you with evidence of specialist
knowledge in transfusion science required to demonstrate your specialist and
independent practice capabilities.”
This implies that it won’t actually
teach me anything, but just provide evidence of what I already know. But I
wouldn’t mind taking
the course anyway
But…
I won’t say that the cost was hidden, but
it certainly wasn’t obvious. After a few minutes I found that if I were to take
this course it would cost just nine quid short of nine hundred pounds. Back in
the day employers used to pay for this sort of thing for their staff. Today I’d
have to shell out. I suppose these people make their money because they are now
dealing predominantly with a generation which is used to paying for its
education.
I can remember when this course was
first launched. It was supposedly going to be a compulsory pre-requisite for
anyone working in a blood bank. That never happened, but it could have been a
good thing for health care at large if not for my pocket.
Am I being such a reactionary old
leftie in thinking that blood banks might be better served by making these
courses more accessible to their target audience?
The nice people at the Stem Cell Evidence Alert sent out their newsletter today. As is the case with most of their communications, much of it went over my head. But reading the abstracts gave me a little insight into some recent developments in the world of haematological malignancies.
ARTICLE OF THE MONTH Reduced-intensity
versus myeloablative conditioning in cord blood transplantation for AML
(40-60 years) across highly mismatched HLA barriers - On behalf of
Eurocord and the Cellular Therapy & Immunobiology Working Party
(CTIWP) of EBMT. |
|
|
